From new biomarkers to emerging lipid-lowering therapies. What do the new2026 American dyslipidemia guidelines tell us?. Rev. Fed. Arg. Cardiol. [Internet]. 2026 Jun. 30 [cited 2026 Oct. 5];55(2):79-86. Available from: https://www.revistafac.org.ar/ojs/index.php/revistafac/article/view/856